{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-004956","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2026-06-18T13:19:55+00:00","discovered_at":"2026-06-18T13:21:00.330163+00:00","generated_at":"2026-06-18T13:21:04.414887+00:00","sec_items":["8.01","3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Valion Bio issues $250K in Series B Preferred and warrants to 3i, LP","bullets":["Issued 250 Series B Preferred shares at $1,000 each and a warrant for 156,026 common shares at $0.61628 per share.","Aggregate purchase price of $250,000 received from 3i, LP.","Securities issued under Section 4(a)(2) and Rule 506(b) exemption from registration.","Purchase agreement originally with an investor, assigned to 3i, LP on December 9, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-004956","json":"https://secwatch.observer/filing/0001683168-26-004956.json","markdown":"https://secwatch.observer/filing/0001683168-26-004956.md","text":"https://secwatch.observer/filing/0001683168-26-004956.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826004956/0001683168-26-004956-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826004956/valion_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T13:21:04.414887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}